Elevation of ISG15 promotes diabetic kidney disease by modulating renal tubular epithelial cell pyroptosis
Clinical and Translational Medicine · 2025-06 · 15 (6)
DOI: 10.1002/ctm2.70337 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical and Translational Medicine, online erschienen am 03.06.2025. Verfasst von Lingzhi Huang und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China,…. Hauptthemen laut MEDLINE: Pyroptosis, Diabetic Nephropathies, Cytokines, Kidney Tubules. Die Arbeit wurde bisher 22-mal zitiert (Crossref) und nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Fibrosis and inflammation in the renal tubular epithelial cells (TECs) are key contributors to the pathology of diabetic kidney disease (DKD). Nevertheless, the precise triggers of these processes remain unclear. This study aimed to explore the role of interferon‐stimulated gene 15 (ISG15) in the injury of TECs induced by high glucose (HG) conditions and its implications for the development of DKD.
Methods
ISG15 knockout (ISG15 KO) mice injected with streptozotocin‐treated mice on a high‐fat diet were used to investigate its role in DKD. Cellular models with ISG15 knockdown were exposed to HG conditions to assess the effects of ISG15 on cellular responses. Subsequently, we evaluated the impact of ISG15 on pyroptosis, a form of programmed cell death, to understand its potential role in DKD pathology. Furthermore, RNA sequencing (RNA‐seq) and molecular biology techniques were employed to explore the signalling pathways potentially regulated by ISG15.
Results
We first confirmed an up‐regulation of ISG15 within the renal tubule in DKD. The deletion of ISG15 alleviated renal functional damage, fibrosis and inflammation, which correlated with reduced ISGylation levels. Mechanistic investigation revealed that HG stimulation in TECs disrupted the mtDNA–cGAS–STING signalling, which exacerbates the DKD through the NLRP3–CASP1–GSDMD axis. Furthermore, we uncovered a bidirectional regulatory loop between STING and ISG15, with STING enhancing ISG15 expression upstream and ISG15 modulating STING expression through ISGylation.
Conclusion
ISG15–mtDNA–STING emerges as a critical hub that integrates the processes of pyroptosis, fibrosis and inflammation. Therapeutic interventions that target this signalling network at various levels may pave the way for innovative treatments for DKD. Key points ISG15 is highly expressed in both DKD mice and renal tubular epithelial cell cultured in HG condition. ISG15 promotes DKD pyroptosis via NLRP3–CASP1–GSDMD axis. ISG15–mtDNA–STING emerges as a critical hub that integrates the processes of pyroptosis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacy, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, Anhui, China.
- Anhui Provincial Key Laboratory of Precision Pharmaceutical Preparations and Clinical Pharmacy, The First Affiliated Hospital of USTC, Hefei, Anhui, China.
ORCID-Profile: Liqin Tang
Zitieren
APA
Huang, L., Chen, X., Shao, Y., Deng, S., Wang, C., Chen, J., Xie, Y., Yuan, S., & Tang, L. (2025). Elevation of ISG15 promotes diabetic kidney disease by modulating renal tubular epithelial cell pyroptosis. Clinical and Translational Medicine, 15(6). https://doi.org/10.1002/ctm2.70337
Vancouver
Huang L, Chen X, Shao Y, Deng S, Wang C, Chen J, et al. Elevation of ISG15 promotes diabetic kidney disease by modulating renal tubular epithelial cell pyroptosis. Clinical and Translational Medicine. 2025;15(6). doi:10.1002/ctm2.70337
BibTeX
@article{Huang2025,
author = {Huang, Lingzhi and Chen, Xinyi and Shao, Yawen and Deng, Shujun and Wang, Chen and Chen, Jianqiao and Xie, Yongsheng and Yuan, Siming and Tang, Liqin},
title = {Elevation of ISG15 promotes diabetic kidney disease by modulating renal tubular epithelial cell pyroptosis},
journal = {Clinical and Translational Medicine},
year = {2025},
volume = {15},
number = {6},
doi = {10.1002/ctm2.70337}
}
EUVIMED